Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$0.23 - $0.35 $11,500 - $17,500
-50,000 Reduced 16.67%
250,000 $57,000
Q4 2023

Feb 14, 2024

SELL
$0.21 - $0.36 $42,000 - $72,000
-200,000 Reduced 40.0%
300,000 $96,000
Q1 2023

May 12, 2023

BUY
$0.36 - $1.0 $180,000 - $500,000
500,000 New
500,000 $330,000
Q2 2021

Mar 09, 2022

SELL
$1.52 - $3.62 $228,000 - $543,000
-150,000 Closed
0 $0
Q1 2021

Mar 09, 2022

BUY
$0.9 - $6.32 $135,000 - $948,000
150,000 New
150,000 $488,000

Others Institutions Holding ASXC

About ASENSUS SURGICAL, INC.


  • Ticker ASXC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 236,719,008
  • Market Cap $82.9M
  • Description
  • Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical int...
More about ASXC
Track This Portfolio

Track Alpha Centric Advisors LLC Portfolio

Follow Alpha Centric Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Centric Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Centric Advisors LLC with notifications on news.